Page last updated 7/6/2022
Find resources on COVID-19 vaccines information and policies, interim guidance for care, data reports on Children, COVID, and vaccines, help for pediatric practices, town hall sessions, advocacy resources, and more. Visit the main COVID-19 Updates page here.
As of June 30, about 75,999 child COVID-19 cases were reported in the U.S., with children representing 18.7% of the weekly reported cases. Since the beginning of the pandemic, children represented 19% of total cumulated cases (over 13.77 million child cases). Read more here. As of June 29, about 27.5 million US children under age 18 have received at least one dose of COVID-19 vaccine, including 69% of 12-17 year-olds. Of these, 14.9 million children and adolescents ages 12-17 are fully vaccinated, representing 59% of 12-17 year-olds. Among children ages 5-11, 10.2 million children have received at least 1 dose representing 36% of 5-11 year-olds, and 8.3 million children 5-11 (29%) are fully vaccinated. However, child vaccination rates vary widely across states. Read more here.
Project Firstline is a CDC national training collaborative offering timely infection control training to front-line health care workers and the public health workforce in the fight against infectious disease threats.
Updated Health Recommendations
DSHS has revised the health recommendations for all vaccinated and unvaccinated individuals, as well as those for child care centers and youth camps.
- Opening the State of Texas
- Information for Public Health: includes resources for Disease Reporting &Case Definitions, Contact Tracing, Isolation Precautions, Laboratory Testing, MIS-C, Persons Under Monitoring, and Persons Under Investigation
- Find Therapeutics: use the US HHS Therapeutic locator for locations with medications
- CDC HAN: Using Therapeutics to Prevent and Treat COVID-19 (12/31/2021)
- AAP: Management Strategies in Children and Adolescents with Mild to Moderate COVID-19 (including information about Monoclonal Antibody Therapy)
- NIH COVID-19 Treatment Guidelines include statements on COVID-19 therapies
- Statement on Patient Prioritization for Outpatient Therapies (updated 3/24/2021)
- Statement on Therapies for High-Risk, Nonhospitalized Patients (updated 4/8/2021)
- Statement on Paxlovid Drug-Drug Interactions (updated 2/24/2021)
- Anti-SARS-CoV-2 Antibody Products - summarize the data on these products
- HHS Office of Assistant Secretary for Preparedness and Response
- COVID-19 Therapeutics (ASPR)
- Side-by-Side Overview of COVID-19 Therapeutics (ASPR) (table outlining available outpatient therapies)
- COVID-19 Therapeutics Decision Aid (ASPR) (flow chart for patients 12 and older weighing 40 kg+)
- DSHS Therapeutics Resources
- COVID-19 Therapeutics Product Guide
- COVID-19 Information for Therapeutics Providers
- COVID-19 Therapeutics - Product Information
- Information for Hospitals and Healthcare Professionals on Therapeutics
- How to Become a Therapeutic Provider: to order therapeutics, providers must have an AmerisourceBergen Account and VAOS access. Learn more with the COVID-19 Therapeutics Enrollment Guide and email firstname.lastname@example.org with questions or issues.
- Ordering: Health Partner Ordering Portal (HPOP) FAQs
- HHS Therapeutics Locator
- TMA: Chart Compares COVID Therapeutics
Test to Treat
US HHS has launched the Test to Treat program where people are able to get tested and – if they are positive and treatments are appropriate for them – receive a prescription from a health care provider, and have their prescription filled all at one location.
A web-based site locator is now available to find Test to Treat program locations. It also lists pharmacies where any provider can send prescriptions for their patients. Those who may have difficulty accessing the internet or need additional support locating a Test to Treat site can call 1-800-232-0233 (TTY 1-888-720-7489) to get help in English, Spanish, and more than 150 other languages – 8am to midnight ET, 7 days a week. The Disability Information and Access Line (DIAL) is also available to specifically help people with disabilities access services. To get help, call 1-888-677-1199, Monday-Friday from 9am to 8pm ET or email DIAL@usaginganddisability.org
Monoclonal Antibody Treatments
- 1/03/22 DSHS letter to therapeutics providers (PDF) for an update on mAbs and the Omicron variant.
- See the 12/29/21 DSHS letter to therapeutics providers (PDF) for information on the recently authorized LAAB and oral antiviral therapeutics for COVID-19.
- COVID-19 Monoclonal Antibody Therapeutics Communications Toolkit
Providers with questions about monoclonal antibodies or ordering can contact email@example.com or call Provider Support at 833-832-7068, option 0.
- HHSC: Merck Oral COVID-19 drug, Molnupiravir, Added to Formulary (1/6/2022)
- Vendor Drug Program Updates:
WHO: Update on Omicron
For more on vaccines, visit Vaccine News and Updates.
AAP News: CDC issues advisory on management of 'COVID-19 rebound' after Paxlovid treatment (5/31/2022)
AAP News: FDA authorizes nonprescription test for COVID, RSV, flu (5/16/2022)
AAP News: CDC: 75% of children, adolescents have had COVID-19 (4/26/2022)
FDA: FDA updates Sotrovimab emergency use authorization (3/30/2022, updated 4/5/2022)
- NPR: Moderna wants the FDA to authorize its COVID-19 vaccine for kids under 6 (3/23/2022)
AAP News: Study: In-school COVID spread reduced by 72% with universal masking (3/9/2022)
EdWeek: Mask Mandates Cut COVID-19 Spread in Schools, Studies Find (3/9/2022)
US News: Most Americans Don’t Need to Wear Masks Indoors Under New CDC COVID-19 Guidance (2/25/2022)
- FDA: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant (2/11/2022)
- AAP: AAP Updates Interim Pandemic Guidance: Urges In-School Learning be Prioritized (1/28/2022)
- TMA: FDA Halts Use of Two Antibody Treatments to Fight COVID (1/25/2022)
- NBC News: CDC updates mask guidance, says N95s offer 'highest protection' (1/14/2021)
- MMWR: Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years (1/14/2022)
- MMWR: Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 years — United States, March 1, 2020–June 28, 2021 (1/14/2022)
- AAP News: New COVID-19-related ICD-10-CM codes take effect (1/13/2022)
With the release of the CDC's new Community Levels risk measures in February 2022, the CDC relaxed its mask guidance. According to this guidance, masks should be worn when Community Levels are High. The CDC does state that some community settings (such as schools) might include additional layers of protection based on the setting. As of July 27, 2021, the CDC recommends universal indoor masking for all teachers, staff, students, and visitors to K-12 schools, regardless of vaccination status. Children should return to full-time in-person learning in the fall with layered prevention strategies in place.
- *An official update of this page is still pending as of 3/15/2022. Currently, the CDC's COVID-19 community Levels recommendation align precautions for educational settings with those for other community settings.* CDC: guidance for schools, child care, and colleges. This page includes information for administrators, mitigation strategies for preventing transmission of COVID-19, and resources for parents, teachers, and staff. (last updated 2/7/2022)
- AAP: COVID-19 Guidance for Safe Schools and Promotion of In-Person Learning (1/28/2022).
- DSHS: Communicable Disease Chart for Schools and Child-Care Centers (8/4/2021), Texas Public Schools COVID-19 Data
- TEA/DSHS released a Decision Tree for COVID-symptomatic persons as a reference guide.
- TEA: Public Health Guidance (1/7/2022), COVID-19 support and guidance resources.
- Return to School/Return to Play
- See above for Quarantine and Isolation resources
- AAP Interim Guidance for Safe Schools and Promotion of In-Person Learning
- AAP COVID-19 Interim Guidance: Return to Sports and Physical Activity
- AAP Return to play after COVID-19 infection algorithm
- TMA Return to School Letter
- TMA Decision Tree Tool for School Nurses
- AAP: Face Masks and Other Prevention Strategies (3/23/2022)
- Mask Testing Data Sheet from Your Local Epidemiologist
- CDC: Types of Masks and Respirators (posted 1/14/2022)
- Printable resources and posters on masks, hand washing, and general info can be found here, from The ABC Science Collaborative (Duke School of Medicine/Clinical Research Institute)
- AAP: Mask Mythbusters: 5 Common Misconceptions about Kids & Cloth Face Coverings (7/21/2021)
- CDC: Use Masks to Slow the Spread of COVID-19 (Aug 2021)
- TPS Physician Letter for Parents and Families - Mask Guidance
- COVID-19 Physician Form for Student Mask Exemption
- AAP News: How to handle requests for medical clearance, mask exemptions during COVID-19 (10/9/2020)
- DSHS: #HealthyTexas COVID-19 Communication Tools, COVID-19 Vaccine Communication Tools
- CDC: Healthcare Provider Communication Toolkit which includes factsheets, social media graphics, videos, and printable resources.
- TMA: COVID-19 Social Media Toolkit, Vaccines Defend What Matters Social Media Toolkit
- AAP: A COVID-19 toolkit to help pediatricians boost efforts to get children ages 12 and older vaccinated
- AAP: EQIPP module on Effective COVID-19 Vaccine Conversations (free)
- Fact Sheet for parents and families: FAQs on the COVID-19 Vaccine for Children (English, Spanish)
- COVID-19 Physician Wellness Guide
- DSHS COVID-19 Toolkit
- Messages from TPS President Dr. Tammy Camp
- Messages from TPS Executive Director, Tricia Hall
- TPS/TMA Letter to HHSC re: Pediatrician Viability in Medicaid
- Advocacy COVID-19 related efforts
- For information on parenting resources related to COVID-19, please visit our Parent Resources page.
- TPS Town Hall Series (November 2021, January and July 2022)
- AAP Interactive Town Hall Series on COVID-19: The AAP hosts a bi-weekly series of virtual town halls linking members with leading experts to discuss emerging issues related to caring for patients and families during the COVID-19 pandemic. Click here to see past sessions.
TPS CME and MOC Webinar: MIS-C and Mimics (May 26, 2021)
- TPS Webinar: How COVID-19 Spreads: A Review (May 10, 2021)
- How Respiratory Droplets Spread COVID-19 (April 29, 2021)
- CMS Lessons from the Frontlines: COVID-19 (July 17, 2020)
- CDC COCA Webinar: Clinical Management of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Covid-19 (July 16, 2020)
- Webinar Recording: Telemedicine Keys to Success
Below are tools for implementing telemedicine including resources on payment, coding, vendor selection, and execution.
- AAP Guidance: Telehealth Payer Policy in Response to COVID-19
- AAP Guidance: Coding for Telemedicine
- AAP Telehealth Workflows and Implementation Resources
- AAP Telehealth and COVID-19 Webinar (3/24/2020)
- AAP State Notices on Telehealth Policy
- American Telehealth Association (ATA) Resource Page
- TMA Telemedicine Vendor Evaluation Form
- HHSC: Texas Health Steps Telemedicine Guidance for Providers FAQs (6/16/2020)
- HHSC: Medicaid CHIP COVID-19 Information Sessions
- TMA List of Telephone Only Consultations and Payments: Lists payers and what they are currently covering. (6/29/2020)
- Telemedicine in Texas Resource Page (TMA): Provides a wide variety of information regarding providing telemedicine during the Coronavirus pandemic including how to get started, the latest updates, and information on different payer policies.
- HHSC: COVID-19 At-home Test Kits Available as a Pharmacy Benefit (12/22/2021)
- DSHS: COVID-19 Testing Information, COVID-19 Test Collection Sites - Map (9/20/2021)
- AAP: COVID-19 Testing Guidance (9/1/2021)
- FDA: EUA list for Antigen and Molecular tests, FAQs on Testing for SARS-CoV-2 - Includes information on manufacturers distributing diagnostic and serology tests (1/22/2022)
- AMA: Considerations for Physicians Ordering SARS-CoV-2 PCR Diagnostic Testing (8/20/2020)
Testing Overview (1/21/2022)
- Testing Strategies for SARS-CoV-2 (12/28/2021)
- Guidance for Healthcare Workers about COVID-19 Testing (6/14/2021)
- Interim Guidance for Antigen Testing for SARS-CoV-2 (1/20/2022)
- HHS: Coronavirus Provider Information page includes information on flexibilities providers may request. Learn more at the monthly HHSC Medicaid/CHIP COVID-19 Info Sessions. (8/5/2021)
- TPS: HHS Announces Enhanced Provider Portal, Relief Fund Payments for Safety Net Hospitals, Medicaid & CHIP Providers (6/9/20)
- AAP: Small Business Guidance for Pediatric Practices (4/6/2020)
- TMA Guide for Practice Finances (4/2/2020) and COVID-19 Practice Viability Toolkit (2020)
- TMA: Medicine Pushes Texas Medicaid to Help Save Primary Care (5/7/20)
- HRSA Update: COVID-19 Uninsured Program Portal Now Open: HRSA has opened the portal for physicians to register if they wish to seek reimbursement for COVID19 related testing and treatment for uninsured patients. Payments will begin May 6 until the funds allocated for this program have been spent. Access the portal here and read about FAQs here.
- SBA Small Business Guidance and Loan Resources
- CARES Act Resources:
- TMA: Catching Up After COVID-19: Using Well-Child Visits (7/3/2021)
- CDC: Well-Child Visits and Recommended Vaccinations Are Essential – includes an infographic and vaccination schedules (6/17/2021)
- AAP: Hybrid Well Child Visits in the Age of Covid (3/2021)
- AAP: Guidance on Providing Pediatric Well-Care During COVID-19 (1/6/2021)
- DSHS: Impacts of COVID-19 on TVFC Vaccine Administration (Updated 9/16/2020)
- HHSC: Texas Health Steps Telemedicine Guidance for Providers FAQs (6/16/2020)
- HHSC: Medicaid CHIP COVID-19 Information Sessions
- TMA: PPE Vendor List (updated 7/1/2021)
- CDC: Using PPE (8/19/2020)
- DSHS: Personal Protective Equipment
- PPE and COVID-19 Supplies through Amazon Business: Amazon to offer a special business discount for AAP members (9/22/2020)